Literature DB >> 9520450

High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression.

A L Rothermel1, D C Altieri.   

Abstract

The antigen recognition of a profoundly immunosuppressive mAb, mAb 2E1, in vivo was investigated. In addition to the 62-kDa effector cell protease receptor 1, mAb 2E1 bound the 32-kDa T cell adhesion receptor E2 (CD99) and the 86-kDa p80 subunit of the nuclear antigen complex Ku. These molecules share no overall sequence similarity. Peptide mapping experiments identified the mAb 2E1 cross-reacting epitopes as the sequences 66GSFSDADLAD75 in E2 and 571GGAHFSVSSLAEG583 in p80 of Ku, sharing a minimal homology motif FSXXXLA, in which X is a nonconserved amino acid. Each of these peptides separately inhibited the binding of mAb 2E1 to E2, effector cell protease receptor 1, and p80 of Ku in a dose-dependent manner. Scatchard plot analysis of 125I-labeled mAb 2E1 binding to peripheral blood mononuclear cells revealed a high-affinity interaction with a dissociation constant of 7 x 10(-10) M. An anti-E2 mAb bound the same epitope 66GSFSDADLAD75 recognized by mAb 2E1 but failed to react with p80 of Ku and was not immunosuppressive. These findings demonstrate that high-affinity cross-reacting mAbs can be generated by mimicry of a minimal surface on unrelated molecules. This model of minimal mimicry may determine the nuclear reactivity of certain autoantibodies to Ku and contribute to aberrant immunosuppression in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520450      PMCID: PMC19920          DOI: 10.1073/pnas.95.7.3816

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Molecular basis of antigen mimicry by an anti-idiotope.

Authors:  B A Fields; F A Goldbaum; X Ysern; R J Poljak; R A Mariuzza
Journal:  Nature       Date:  1995-04-20       Impact factor: 49.962

2.  Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease.

Authors:  S K Ray; C Putterman; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA.

Authors:  L Jacob; M A Lety; J F Bach; D Louvard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Cross--reactivity of antilymphocyte and antinuclear antibodies in systemic lupus erythematosus.

Authors:  R P Searles; R P Messner; A D Bankhurst
Journal:  Clin Immunol Immunopathol       Date:  1979-11

5.  Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders.

Authors:  T Mimori; J A Hardin; J A Steitz
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

6.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.

Authors:  R Levy; J Dilley; R I Fox; R Warnke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection.

Authors:  H J Ditzel; S M Barbas; C F Barbas; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits.

Authors:  M P Madaio; J Carlson; J Cataldo; A Ucci; P Migliorini; O Pankewycz
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

9.  Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway.

Authors:  M I Reinhold; F P Lindberg; G J Kersh; P M Allen; E J Brown
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

10.  Human autoantibodies that react with both cell nuclei and plasma membranes display specificity for the octamer of histones H2A, H2B, H3, and H4 in high salt.

Authors:  O P Rekvig; K Hannestad
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  1 in total

1.  High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia.

Authors:  Larizbeth A Romero; Takamitsu Hattori; Mohamed A E Ali; Gayatri Ketavarapu; Akiko Koide; Christopher Y Park; Shohei Koide
Journal:  J Mol Biol       Date:  2021-12-24       Impact factor: 5.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.